Kun-Ming Rau

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

Jin‐Shing Chen, Jaw-Ching Liu, Lei Shen et al. · Cancer Gene Therapy · 2004 · 113 citations

Survivin Promoter, Oncogenic Agent, Medicine +10

Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response

Kun-Ming Rau, Chien-Ting Liu, Yu-Chiao Hsiao et al. · Journal of Clinical Medicine · 2020 · 41 citations · Full text

Impact of Combined Hospice Care on Terminal Cancer Patients

Song-Seng Loke, Kun-Ming Rau, Chih-Fang Huang · Journal of Palliative Medicine · 2011 · 37 citations

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

Ying‐Chun Shen, Tsung‐Hao Liu, Alan Nicholas et al. · Journal of Clinical Oncology · 2024 · 25 citations · Full text

Increased cumulative doses and appearance of hand‐foot skin reaction prolonged progression free survival in sorafenib‐treated advanced hepatocellular carcinoma patients

Wen‐Tsan Chang, Sheng‐Nan Lu, Kun-Ming Rau et al. · The Kaohsiung Journal of Medical Sciences · 2018 · 14 citations · Full text